[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100507462":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":26,"responsibleParty":87,"collaborators":10,"id":89,"slug":90,"hasResults":91,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":10,"eligibilityCriteria":95,"healthyVolunteers":91,"sex":96,"minAge":10,"maxAge":10,"enrollmentInfo":97,"targetDuration":10,"studyType":100,"phases":10,"briefSummary":101,"conditions":102,"keywords":104,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":118},{"fullName":5,"class":6},"Lifetech Scientific (Shenzhen) Co., Ltd.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"ASD subjects",null,"Patients with a confirmed diagnosis of Atrial Septal Defect (ASD) and implanted with the investigational device.",[13],"Device: CeraFlex™ Atrial Septal Defect (ASD) Closure System",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","CeraFlex™ Atrial Septal Defect (ASD) Closure System","The CeraFlex™ ASD Occluder have two types of occluders, CeraFlex™ ASD Occluder and CeraFlex™ Multi-fenestrated (Cribriform) ASD Occluder. The CeraFlex™ ASD Occluder is percutaneous, transcatheter closure devices for the non-surgical closure of atrial septal defects.",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Rae Gong","CONTACT","(86-755)-86026250-6957","gongrui@lifetechmed.com",[27,42,53,64,72],{"facility":28,"status":29,"city":30,"state":10,"zip":10,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Hospital Pequeno Príncipe","RECRUITING","Curitiba","Brazil","BR",{"type":34,"coordinates":35},"Point",[36,37],-49.27306,-25.42778,{"lat":37,"lon":36},[40],{"name":41,"role":23,"phone":10,"phoneExt":10,"email":10},"Leo Solarewicz",{"facility":43,"status":29,"city":44,"state":10,"zip":10,"country":31,"countryCode":32,"cosmosGeoPoint":45,"geoPoint":49,"contacts":50},"Santa Casa de Misericórdia de Porto Alegre","Porto Alegre",{"type":34,"coordinates":46},[47,48],-51.23019,-30.03283,{"lat":48,"lon":47},[51],{"name":52,"role":23,"phone":10,"phoneExt":10,"email":10},"Carlo Pilla",{"facility":54,"status":29,"city":55,"state":10,"zip":10,"country":31,"countryCode":32,"cosmosGeoPoint":56,"geoPoint":60,"contacts":61},"HCOR - Associação Beneficente Síria","São Paulo",{"type":34,"coordinates":57},[58,59],-46.63611,-23.5475,{"lat":59,"lon":58},[62],{"name":63,"role":23,"phone":10,"phoneExt":10,"email":10},"Carlos Pedra",{"facility":65,"status":29,"city":55,"state":10,"zip":10,"country":31,"countryCode":32,"cosmosGeoPoint":66,"geoPoint":68,"contacts":69},"Hospital Beneficência Portuguesa",{"type":34,"coordinates":67},[58,59],{"lat":59,"lon":58},[70],{"name":71,"role":23,"phone":10,"phoneExt":10,"email":10},"Salvador Cristóvão",{"facility":73,"status":29,"city":74,"state":10,"zip":10,"country":75,"countryCode":76,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"Onassis Cardiac Surgery Center","Kallithea","Greece","GR",{"type":34,"coordinates":78},[79,80],23.7,37.95,{"lat":80,"lon":79},[83,85],{"name":84,"role":23,"phone":10,"phoneExt":10,"email":10},"Spyros Rammos",{"name":86,"role":23,"phone":10,"phoneExt":10,"email":10},"Ioannis Papagiannis",{"type":88,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100507462","lifetech-ceraflex-asd-closure-system-post-market-clinical-follow-up-100507462",false,"NCT05887700","Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up","A Multi-center, Single-arm, Real-world Registry Assessing the Clinical Use of the Lifetech CeraFlex™ ASD Closure System","Inclusion Criteria:\n\n1. Patients with a confirmed diagnosis of Atrial Septal Defect (ASD) and implanted with the investigational device as per IFU instructions.\n2. Patients or legally authorized representatives have signed Data Release Consent or equivalent documents.\n\nExclusion Criteria:\n\nPatients did not conduct any follow up visit after hospital discharge.","ALL",{"count":98,"type":99},145,"ESTIMATED","OBSERVATIONAL","The objective of this post-market registry is to assess the clinical use of the Lifetech CeraFlex™ Closure System in a real-world and on-label fashion.",[103],"Atrial Septal Defect",[105,103,106,107,108],"Lifetech","ASD","CeraFlex","ASD Closure System","2026-05-21",{"date":111,"type":112},"2026-05-26","ACTUAL",{"date":114,"type":112},"2024-07-09",{"date":116,"type":99},"2027-06-30",{"name":5,"class":6},5]